OMNI HEALTH INC

As of January 31, 2017, OMNI HEALTH INC carries a market capitalization of 46.94M, placing it among publicly traded companies globally. Its enterprise value stands at 47.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of January 31, 2017, OMNI HEALTH INC has 975.83M shares outstanding.

As of January 31, 2017, OMNI HEALTH INC trades at a trailing price-to-earnings ratio of 79.23. The price-to-sales ratio is 11.21, and the price-to-book ratio stands at 14.57.

These figures are as of January 31, 2017. The EV/Sales ratio of 14.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 47.85M versus a market cap of 46.94M, with the gap driven by net debt and cash on the balance sheet.

As of January 31, 2017, OMNI HEALTH INC maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended January 31, 2017. Return on assets (ROA) stands at 18.63, measuring how efficiently the asset base is converted into earnings. Inventory turnover of 16.25 indicates how many times OMNI HEALTH INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended January 31, 2017, OMNI HEALTH INC generated 3.37M in revenue and converted that into 476,105.00 in net income, yielding earnings per share of 0.00. EBITDA reached -443,426.00, while operating income came in at -461,516.00.

As of January 31, 2017, OMNI HEALTH INC holds 7,649.00 in cash and equivalents against 924,985.00 in total debt, resulting in a net debt position of 917,336.00. Total book value stands at 3.22M, with working capital of 86,473.00 providing operational flexibility.

OMNI HEALTH INC produced -481,843.00 in operating cash flow over the twelve months ended January 31, 2017. After subtracting -317,292.00 in capital expenditures, free cash flow totaled -799,135.00 - equivalent to 0.00 per share.

Over the twelve months ended January 31, 2017, OMNI HEALTH INC posted a gross margin of 26.77, reflecting its pricing power and cost economics. The operating margin of -13.71 and net profit margin of 14.14 provide insight into operational efficiency.

These figures cover the twelve months ended January 31, 2017. Free cash flow yield is negative at -2.12: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.61, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to OMNI HEALTH INC shareholders.

As of January 31, 2017, OMNI HEALTH INC has an Altman Z-Score of 16.18, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.